Polycystic kidney disease in Han:SPRD Cy rats is associated with elevated expression and mislocalization of SamCystin.
Polycystic kidney disease (PKD) in Han:SPRD Cy rats is caused by a missense mutation in Anks6 (also called Pkdr1), leading to an R823W substitution in SamCystin, a protein that contains ankyrin repeats and a sterile alpha motif (SAM). The cellular function of SamCystin and the role of the Cy (R823W) mutation in cyst formation are unknown. In normal SPRD rats, SamCystin was found to be expressed in proximal tubules and glomeruli; protein expression was highest at 7 days of age and declined by ∼50-60% at 45-84 days of age. In Cy/+ and Cy/Cy kidneys, expression of SamCystin was lower than in +/+ kidneys at 3 and 7 days but became elevated at 21 days. Immunohistochemical analysis revealed that SamCystin was distributed on the brush border of proximal tubules in normal rat kidneys. In Cy/+ kidneys, there were robust SamCystin staining in cyst-lining epithelial cells and loss of apical localization, and increased number of PCNA-positive cells in cyst-lining epithelia. Verapamil, an L-type Ca(2+) channel blocker, accelerated PKD progression in this model and caused a further increase in the expression and abnormal distribution of SamCystin. We conclude that aberrant expression and mislocalization of R823W SamCystin lead to increased cell proliferation and renal cyst formation.
Nagao
Shizuko
S
The Kidney Institute, Dept. of Medicine, Univ. of Kansas Medical Center, 3901 Rainbow Blvd., Kansas City, KS 66160-3018, USA.
Morita
Miwa
M
Kugita
Masanori
M
Yoshihara
Daisuke
D
Yamaguchi
Tamio
T
Kurahashi
Hiroki
H
Calvet
James P
JP
Wallace
Darren P
DP
D000818:Animals; D015153:Blotting, Western; D002121:Calcium Channel Blockers / Q000494:pharmacology; D049109:Cell Proliferation; D004252:DNA Mutational Analysis; D018450:Disease Progression; D005455:Fluorescent Antibody Technique; D005838:Genotype; D007150:Immunohistochemistry; D007668:Kidney / Q000378:metabolism / Q000473:pathology; D020125:Mutation, Missense / Q000235:genetics / Q000502:physiology; D009687:Nuclear Proteins / Q000096:biosynthesis* / Q000235:genetics*; D007690:Polycystic Kidney Diseases / Q000235:genetics* / Q000378:metabolism / Q000473:pathology; D051381:Rats; D017207:Rats, Sprague-Dawley; D014700:Verapamil / Q000494:pharmacology
C532259:Anks6 protein, rat; D002121:Calcium Channel Blockers; D009687:Nuclear Proteins; D014700:Verapamil